Department of Neurobiology, Harvard Medical School, 220 Longwood Avenue, Boston, MA 02115, USA.
Cell. 2010 Mar 5;140(5):704-16. doi: 10.1016/j.cell.2010.01.026.
Angelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiquitin ligase Ube3A, a gene whose mutation has also recently been associated with autism spectrum disorders (ASDs). The function of Ube3A during nervous system development and how Ube3A mutations give rise to cognitive impairment in individuals with Angleman Syndrome and ASDs are not clear. We report here that experience-driven neuronal activity induces Ube3A transcription and that Ube3A then regulates excitatory synapse development by controlling the degradation of Arc, a synaptic protein that promotes the internalization of the AMPA subtype of glutamate receptors. We find that disruption of Ube3A function in neurons leads to an increase in Arc expression and a concomitant decrease in the number of AMPA receptors at excitatory synapses. We propose that this deregulation of AMPA receptor expression at synapses may contribute to the cognitive dysfunction that occurs in Angelman Syndrome and possibly other ASDs.
天使综合征是一种使人衰弱的神经紊乱疾病,由 E3 泛素连接酶 Ube3A 的突变引起,而该基因突变最近也与自闭症谱系障碍(ASD)有关。Ube3A 在神经系统发育过程中的功能以及 Ube3A 突变如何导致患有天使综合征和 ASD 的个体认知障碍尚不清楚。我们在此报告,经验驱动的神经元活动会诱导 Ube3A 的转录,而 Ube3A 可以通过控制 Arc 的降解来调节兴奋性突触的发育,Arc 是一种促进 AMPA 型谷氨酸受体内化的突触蛋白。我们发现神经元中 Ube3A 功能的破坏会导致 Arc 表达增加,同时兴奋性突触处的 AMPA 受体数量减少。我们提出,这种突触处 AMPA 受体表达的失调可能导致天使综合征和可能的其他 ASD 发生认知功能障碍。